These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 31490085)

  • 41. Sanguiin H-6, a constituent of Rubus parvifolius L., inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis and bone resorption in vitro and prevents tumor necrosis factor-α-induced osteoclast formation in vivo.
    Sakai E; Aoki Y; Yoshimatsu M; Nishishita K; Iwatake M; Fukuma Y; Okamoto K; Tanaka T; Tsukuba T
    Phytomedicine; 2016 Jul; 23(8):828-37. PubMed ID: 27288918
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sophorae Flos extract inhibits RANKL-induced osteoclast differentiation by suppressing the NF-κB/NFATc1 pathway in mouse bone marrow cells.
    Kim JM; Lee JH; Lee GS; Noh EM; Song HK; Gu DR; Kim SC; Lee SH; Kwon KB; Lee YR
    BMC Complement Altern Med; 2017 Mar; 17(1):164. PubMed ID: 28335757
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dimethyl fumarate inhibits osteoclasts via attenuation of reactive oxygen species signalling by augmented antioxidation.
    Yamaguchi Y; Kanzaki H; Katsumata Y; Itohiya K; Fukaya S; Miyamoto Y; Narimiya T; Wada S; Nakamura Y
    J Cell Mol Med; 2018 Feb; 22(2):1138-1147. PubMed ID: 29063666
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Four-Octyl itaconate ameliorates periodontal destruction via Nrf2-dependent antioxidant system.
    Xin L; Zhou F; Zhang C; Zhong W; Xu S; Jing X; Wang D; Wang S; Chen T; Song J
    Int J Oral Sci; 2022 May; 14(1):27. PubMed ID: 35637195
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 4-octyl itaconate protects against oxidative stress-induced liver injury by activating the Nrf2/Sirt3 pathway through AKT and ERK1/2 phosphorylation.
    Hu Z; Xu D; Meng H; Liu W; Zheng Q; Wang J
    Biochem Pharmacol; 2024 Feb; 220():115992. PubMed ID: 38128618
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of calmodulin in the regulation of osteoclastogenesis.
    Zhang L; Feng X; McDonald JM
    Endocrinology; 2003 Oct; 144(10):4536-43. PubMed ID: 12960067
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Four-Octyl Itaconate Protects Chondrocytes against H
    Zhang P; Wang X; Peng Q; Jin Y; Shi G; Fan Z; Zhou Z
    Oxid Med Cell Longev; 2022; 2022():2206167. PubMed ID: 35126808
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Non-coenzyme role of vitamin B1 in RANKL-induced osteoclastogenesis and ovariectomy induced osteoporosis.
    Ma Q; Liang M; Wang Y; Ding N; Wu Y; Duan L; Yu T; Lu Y; Xu J; Kang F; Dou C
    J Cell Biochem; 2020 Jul; 121(7):3526-3536. PubMed ID: 32100911
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IRG1/itaconate alleviates acute liver injury in septic mice by suppressing NLRP3 expression and its mediated macrophage pyroptosis via regulation of the Nrf2 pathway.
    Zhou P; Yang L; Li R; Yin Y; Xie G; Liu X; Shi L; Tao K; Zhang P
    Int Immunopharmacol; 2024 Jun; 135():112277. PubMed ID: 38788445
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dimethyl itaconate protects against lippolysacchride-induced mastitis in mice by activating MAPKs and Nrf2 and inhibiting NF-κB signaling pathways.
    Zhao C; Jiang P; He Z; Yuan X; Guo J; Li Y; Hu X; Cao Y; Fu Y; Zhang N
    Microb Pathog; 2019 Aug; 133():103541. PubMed ID: 31100405
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 4-Octyl Itaconate Prevents Free Fatty Acid-Induced Lipid Metabolism Disorder through Activating Nrf2-AMPK Signaling Pathway in Hepatocytes.
    Chu X; Li L; Yan W; Ma H
    Oxid Med Cell Longev; 2022; 2022():5180242. PubMed ID: 35222799
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Siglec-15 is a potential therapeutic target for postmenopausal osteoporosis.
    Kameda Y; Takahata M; Mikuni S; Shimizu T; Hamano H; Angata T; Hatakeyama S; Kinjo M; Iwasaki N
    Bone; 2015 Feb; 71():217-26. PubMed ID: 25460183
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Investigating the role of itaconate in macrophage activation and oxidative stress injury in sepsis-associated acute kidney injury.
    Yang L; Zhou P; Li R; Yin Y; Xie G; Shi L; Zhang P; Tao K
    Mol Biol Rep; 2024 Apr; 51(1):533. PubMed ID: 38642169
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acod1/itaconate activates Nrf2 in pulmonary microvascular endothelial cells to protect against the obesity-induced pulmonary microvascular endotheliopathy.
    Zhu L; Wu Z; Liu Y; Ming Y; Xie P; Jiang M; Qi Y
    Respir Res; 2024 May; 25(1):205. PubMed ID: 38730297
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Artesunate inhibits RANKL-induced osteoclastogenesis and bone resorption in vitro and prevents LPS-induced bone loss in vivo.
    Wei CM; Liu Q; Song FM; Lin XX; Su YJ; Xu J; Huang L; Zong SH; Zhao JM
    J Cell Physiol; 2018 Jan; 233(1):476-485. PubMed ID: 28294321
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Garcinol suppresses RANKL-induced osteoclastogenesis and its underlying mechanism.
    Jia Y; Jiang J; Lu X; Zhang T; Zhao K; Han W; Yang W; Qian Y
    J Cell Physiol; 2019 May; 234(5):7498-7509. PubMed ID: 30471112
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation.
    Hyeon S; Lee H; Yang Y; Jeong W
    Free Radic Biol Med; 2013 Dec; 65():789-799. PubMed ID: 23954472
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Estrogen-related receptor γ negatively regulates osteoclastogenesis and protects against inflammatory bone loss.
    Kim HJ; Kim BK; Ohk B; Yoon HJ; Kang WY; Cho S; Seong SJ; Lee HW; Yoon YR
    J Cell Physiol; 2019 Feb; 234(2):1659-1670. PubMed ID: 30076703
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Skullcapflavone II inhibits osteoclastogenesis by regulating reactive oxygen species and attenuates the survival and resorption function of osteoclasts by modulating integrin signaling.
    Lee J; Son HS; Lee HI; Lee GR; Jo YJ; Hong SE; Kim N; Kwon M; Kim NY; Kim HJ; Lee YJ; Seo EK; Jeong W
    FASEB J; 2019 Feb; 33(2):2026-2036. PubMed ID: 30216110
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Deguelin inhibits RANKL-induced osteoclastogenesis in vitro and prevents inflammation-mediated bone loss in vivo.
    Zhang T; Zhao K; Han W; Yang W; Lu X; Liu Q; Li X; Qian Y
    J Cell Physiol; 2019 Mar; 234(3):2719-2729. PubMed ID: 30078209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.